SOFINNOVA CAPITAL VI FCPR's Net Worth
-$2.61 Million
Who is SOFINNOVA CAPITAL VI FCPR?
SOFINNOVA CAPITAL VI FCPR does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include HOOKIPA Pharma Inc., BioAmber Inc., and Omthera Pharmaceuticals, Inc..
SEC CIK
SOFINNOVA CAPITAL VI FCPR's CIK is 0001441261
Past Insider Trading and Trends
2013 was SOFINNOVA CAPITAL VI FCPR's most active year for acquiring shares with 8 total transactions. SOFINNOVA CAPITAL VI FCPR's most active month to acquire stocks was the month of March. 2021 was SOFINNOVA CAPITAL VI FCPR's most active year for disposing of shares, totalling 8 transactions. SOFINNOVA CAPITAL VI FCPR's most active month to dispose stocks was the month of March. 2013 saw SOFINNOVA CAPITAL VI FCPR paying a total of $18,867,314.50 for 9,708,982 shares, this is the most they've acquired in one year. In 2021 SOFINNOVA CAPITAL VI FCPR cashed out on 728,620 shares for a total of $9,467,262.23, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
HOOKIPA Pharma Inc. (HOOK) Snapshot price: $0.6923
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -9.37% | -328.62K |
$11.60 | -$3,812,386.34 | 3.18M |
Apr 21
| |||
Form 4
| -1.04% | -36.83K |
$13.67 | -$503,570.28 | 3.51M |
Scheduled
|
Mar 29
| ||
Form 4
| -0.98% | -35.17K |
$13.69 | -$481,642.23 | 3.54M |
Scheduled
|
Mar 26
| ||
Form 4
| -0.79% | -28.55K |
$13.12 | -$374,569.19 | 3.58M |
Scheduled
|
Mar 25
| ||
Form 4
| -1.44% | -52.69K |
$13.70 | -$721,615.89 | 3.61M |
Scheduled
|
Mar 24
| ||
Form 4
| -1.08% | -40.00K |
$13.91 | -$556,476.00 | 3.66M |
Scheduled
|
Mar 23
| ||
Form 4
| -1.08% | -40.53K |
$14.54 | -$589,263.02 | 3.7M |
Scheduled
|
Mar 22
| ||
Form 4
| -4.26% | -166.23K |
$14.60 | -$2,427,739.28 | 3.74M |
Scheduled
|
Mar 19
| ||
Form 4
| -0.01% | -300.00 |
$10.00 | -$3,000.00 | 3.91M |
Scheduled
|
Oct 2
| ||
Form 4
| -1.05% | -41.60K |
$12.61 | -$524,476.53 | 3.91M |
Scheduled
|
Sep 15
| ||
Form 4/A
| -0.08% | -3.28K |
$11.78 | -$38,627.58 | 3.96M |
Scheduled
|
Jun 29
| ||
Form 4
| -0.08% | -3.28K |
$11.78 | -$38,627.58 | 3.96M |
Scheduled
|
Jun 29
| ||
Form 4
| -0.32% | -12.48K |
$11.94 | -$149,101.95 | 3.95M |
Scheduled
|
Jul 20
| ||
Form 4
| -0.08% | -3.28K |
$11.78 | -$38,627.58 | 3.96M |
Scheduled
|
Jun 29
| ||
Form 4
| +4,707.24% | 3.88M |
$14.00 |
—
| 3.96M |
Apr 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BioAmber Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +30.11% | 880K |
—
|
—
| 3.8M |
May 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Omthera Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -7.16M |
—
|
—
|
0
|
Jul 18
| |||
Form 4
|
∞
| 7.16M |
$7.56 | $10,065,746.50 | 7.16M |
Apr 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||